EOFlow Co Ltd

EOFlow's capital structure is characterized by a debt-to-equity ratio of 0.61, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is assessed as medium, with a current ratio of 6.02, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's negative operating cash flow of -7,251,161,270 KRW and free cash flow of -8,012,345,990 KRW indicate a significant cash outflow, which could pose challenges in maintaining liquidity and meeting short-term obligations.

In terms of profitability, EOFlow is experiencing substantial losses, with a net income of -8,531,964,120 KRW and an operating income of -8,247,390,400 KRW. The company's return on equity (ROE) is -17.72%, and its return on assets (ROA) is -9.56%, both of which are well below the industry median for medical equipment and supplies firms. These metrics suggest that the company is not generating returns that meet the expectations of its equity holders or effectively utilizing its assets to generate profit.

The company's revenue concentration is not explicitly detailed in the available data, but the absence of segment or geographic breakdowns implies that EOFlow may be operating in a single business line or geographic region. This lack of diversification could expose the company to higher operational and market risks, particularly in a volatile industry like healthcare.

Looking at the company's growth trajectory, there is no specific outlook provided for the current or next fiscal year. However, the significant negative operating and free cash flows suggest that the company is not currently in a growth phase and may be facing operational challenges that could hinder future expansion. The company's capital expenditures of -616,092,270 KRW indicate a reduction in investment in long-term assets, which could further limit its ability to grow or modernize its operations.

The risk assessment for EOFlow highlights a medium liquidity risk, primarily due to its negative operating and free cash flows. The company's dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. However, the company's negative net cash position after subtracting total debt is a key flag that could impact its financial stability and ability to meet obligations.

Recent events or filings that could impact EOFlow's operations or financial position are not detailed in the available data. The absence of specific information on recent filings or transcripts suggests that the company may not have disclosed significant events or changes in its operations or strategy in the latest available reports.

Revenue grew at a 51.7% compound annual rate over the last four years, indicating strong top-line expansion momentum.

Operating income improved by 87.8% year-over-year, demonstrating significant progress in reducing operational losses compared to the prior period.

Free cash flow improved by 79.5% year-over-year, suggesting a meaningful reduction in cash burn relative to the previous fiscal year.

Cash conversion ratio of 0.85 ranks above the cohort median of 0.84, indicating relatively efficient cash generation from operations.

Dilution risk is assessed as low, providing some protection to existing shareholders against immediate equity value erosion from new issuances.

The company reported a net loss of 42.3 billion KRW in the latest fiscal year, highlighting persistent unprofitability and negative earnings.

Credit risk is flagged as high, signaling significant concerns regarding the company's ability to meet its financial obligations and debt requirements.

Operating margin of -6.82% places the company in the bottom quartile of its cohort, indicating severe operational inefficiency compared to peers.

Debt-to-equity ratio of 0.61 is in the bottom quartile of the cohort, indicating higher leverage and financial risk than most peers.